Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)

计划入组 357 人 · 首次发布于 2005 年 9 月 12 日

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

计划入组 262 人 · 首次发布于 2011 年 12 月 1 日

Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063)

计划入组 282 人 · 首次发布于 2011 年 7 月 11 日

Boc5

BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA

C₂₆H₄₁BN₄O₁₀

Boceprevir

C₂₇H₄₅N₅O₅

BOC LIMITED

United Kingdom

Messer Canada Inc.

Canada

Boca Pharmacal LLC

United States

Custom SYNTHIA Search Configuration Cuts Synthesis Route Planning to Hours, Case Study Shows

Lundbeck's Bocunebart Meets Primary Endpoint in Phase IIb Migraine Prevention Trial

Olaparib Before Surgery Shows 100% Survival Rate in BRCA-Mutated Breast Cancer Patients